Willingness to participate in genome testing: a survey of public attitudes from Qatar by Abdul-Rahim, Hanan et al.
Journal of Human Genetics (2020) 65:1067–1073
https://doi.org/10.1038/s10038-020-0806-y
ARTICLE
Willingness to participate in genome testing: a survey of public
attitudes from Qatar
Hanan F. Abdul Rahim1 ● Said I. Ismail2 ● Amel Hassan3 ● Tasnim Fadl2 ● Salma M. Khaled4 ● Bethany Shockley4 ●
Catherine Nasrallah 4 ● Yara Qutteina4 ● Engi Elmaghraby4 ● Heba Yasin2 ● Dima Darwish2 ● Khalid A. Fakhro 5,6,7 ●
Radja Badji2 ● Wadha Al-Muftah2,6 ● Nahla Afifi8 ● Asmaa Althani1,2,8
Received: 23 January 2020 / Revised: 2 July 2020 / Accepted: 3 July 2020 / Published online: 28 July 2020
© The Author(s) 2020. This article is published with open access
Abstract
Genomics has the potential to revolutionize medical approaches to disease prevention, diagnosis, and treatment, but it does
not come without challenges. The success of a national population-based genome program, like the Qatar Genome Program
(QGP), depends on the willingness of citizens to donate samples and take up genomic testing services. This study explores
public attitudes of the Qatari population toward genetic testing and toward participating in the QGP. A representative sample
of 837 adult Qataris was surveyed in May 2016. Approximately 71% of respondents surveyed reported that they were
willing to participate in the activities of the QGP. Willingness to participate was significantly associated with basic literacy in
genetics, a family history of genetic diseases, and previous experience with genetic testing through premarital screening.
Respondents cited the desire to know more about their health status as the principle motivation for participating, while lack
of time and information were reported as the most important barriers. With QGP plans to ramp up the scale of its national
operation toward more integration into clinical care settings, it is critical to understand public attitudes and their
determinants. The results demonstrate public support but also identify the need for more education and individual counseling
that not only provide information on the process, challenges, and benefits of genomic testing, but that also address concerns
about information security.
Introduction
Precision health is a new paradigm that is increasing the use
of genomic technologies for the assessment of susceptibility
to major diseases as well as individual responses to ther-
apeutic regimes [1, 2], thus, increasing the effectiveness of
medical intervention. Increasingly, evidence is pointing to
the influence of precision health on improved treatment and
health outcomes for patients with breast [3], lung [4], and
colorectal [5] cancers. Realizing this potential, and aided by
the rapid evolution of sequencing technology, several
countries have embarked on national projects to character-
ize the genomes of their own populations in preparation for
large-scale implementation in clinical settings [1]. The State
of Qatar in the Arabian Gulf is one of those countries. In
late 2015, Qatar launched the pilot phase of the Qatar
Genome Program (QGP), which is a population-based
genome program aiming to sequence the whole genomes for
a significant proportion of the Qatari population. The pro-
gram has a comprehensive plan to facilitate the imple-
mentation of precision medicine involving drafting genomic
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research regulations and policies, building genomic research
networks, building local human capacity, and expediting the
integration of genomics into the healthcare system. With a
native population of around 300,000 citizens, state of the art
genomic infrastructure, and a centralized and dynamic
health care system, Qatar has all the essential ingredients for
becoming a global model in implementing precision
medicine.
As a population-based program, QGP relies on com-
munity support and engagement, which in turn depends on
the public’s trust and willingness to participate. With the
end of the pilot phase and in preparation for the subsequent
large-scale phases of the program, it was important for QGP
to gauge preparedness and potential challenges at the public
level. To that end, QGP commissioned the Social and
Economic Survey Research Institute (SESRI) in Qatar to
conduct the survey. The survey was conducted among a
representative sample of the Qatari population to measure
public awareness and attitudes related to genetic and
genomic testing as well as willingness to participate in QGP
activities. The findings of this survey address the dearth of
empirical studies on public attitudes toward genetic research
and genome-based health care from the Middle East and
North Africa (MENA) region, where social, legal, and
ethical issues related to genetic testing have been debated.
Outcomes of these surveys are needed for research-based
guidelines and recommendations to inform QGP’s strategic
planning and pave the way for implementation of precision
medicine at a national level.
Population and methods
Sample
The target population for the survey was Qatari adults, aged
18 years or older. At ~98% coverage [6], Qatar has one of
the highest cell phone penetration rates globally [7], making
cell phone based sampling an effective and efficient choice
for drawing a representative sample of the target population.
In this survey, the SESRI of Qatar University, working with
local cellular phone providers, drew a representative cell
phone sample using a list-based dialing technique [8]. The
target sample size for this survey was estimated at 800,
calculated using the standard formula for estimating pro-
portions, with significance level set at 5%:
n ¼ z2 p 1 pð Þ
e2
deff :
Following convention, p was set at 50.0% to identify the
largest sample size requirement [9]. The design effect (deff),
which reflects the relative efficiency of a statistical estimate
based on a complex sample design compared with a sample
of the same size selected by simple random sampling, was
estimated at 1.1 based on previous phone surveys with the
same sample design. Sampling error (e) was set at 3.5%,
which is a reasonable level of sampling error compared with
previous studies in Qatar [10].
Questionnaire development
Researchers designed a semi-structured questionnaire to
collect information related to public perceptions of genetic
testing in general and genomic testing in specific. The
questionnaire was based on an extensive review of public
attitude surveys in a number of countries [11–15], with
adaptations to the local context. The questionnaire included
closed-ended questions covering demographic character-
istics, awareness of genetic and genomic testing, sources of
information on genetic and genomic testing, basic literacy
in genetics, past experience with genetic testing (for
example through premarital testing), family history of
chronic diseases, family history of genetic diseases, will-
ingness to participate in QGP genomic activities, and per-
ceived facilitators and barriers to such participation.
Awareness of genetic testing was asked first (have you
ever heard of genetic tests), and subsequent questions about
sources of information for hearing about genetic tests were
only asked to those who answered affirmatively. To ask
about knowledge of genomic testing, the interviewers used
the following script: “genetic tests that scan an entire
person’s genetic makeup for health risks are currently
available. Have you heard anything about those tests?”
Basic literacy in genetics was assessed using eight questions
(Appendix 1 survey questionnaire). Each question was
judged as “correct” or “incorrect” by the taking the standard
scientific understanding as a baseline. Correct answers
received a score of “1” and incorrect answers a score of “0.”
The final score for scientific literacy was calculated by
summing the number of correct answers. Questions to
measure previous experience with genetic testing gave the
respondent a list of examples of such tests, including
newborn screening, pre-martial genetic screening, and pre-
natal testing. The question about willingness to participate
in QGP activities was asked after giving respondents a
description of QGP aims. Additional open-ended questions
about facilitators and barriers to participation in QGP
activities allowed respondents to express in their own words
responses that were not anticipated by the researchers.
Questions were initially written in English. A profes-
sional translator translated them into Arabic, and bilingual
researchers carefully checked the translations. The ques-
tionnaire was pilot-tested on 30 respondents (not included
in the final study) to ensure clarity and understandability of
all terms and questions to a layperson. Pretest results were
used to refine question wording, response categories,
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introduction script, transitions, interviewer instructions, and
interview length.
Survey administration
The public opinion survey was conducted in May 2016 using
the Computer Assisted Telephone Interview module of the
survey management software BLAISE (Statistics Nether-
lands). Twenty-three experienced Arabic-speaking survey
interviewers, who are long-term residents of Qatar, with
university or at least above secondary education were trained
both on the protocol for conducting phone interviews and on
the survey questions. To maximize the likelihood of reaching
respondents, interviewers made calls over different times of
the day across different days of the week.
Cellular phone numbers of respondents were released to
interviewers in batches to ensure that call procedures were
followed per protocol for all numbers. The use of batches
also improved the representativeness of the survey by bal-
ancing the distribution of phone numbers across respondent
characteristics. For every phone number in the sample, there
were at least six attempts to complete the interview. Phone
numbers with break-offs and soft refusals were transferred
to dedicated interviewers with advanced experience.
Interviewers obtained informed consent from potential
responders by first introducing themselves and the subject
of the survey and then explaining the voluntary nature of
participation and the confidentiality of responses. Inter-
viewees were given the opportunity to ask any clarification
questions before agreeing to take part in the survey.
Statistical analysis
Data from the surveys were analyzed using STATA version
14.0. Survey weights were used in the calculation of
reported percentages, bivariate and multivariate analyses
performed. Weights were constructed from the sample
selection probability (base weights), adjustment factor to
account for nonresponse, and post-stratification calibration.
Probabilities (p values) for statistical significance (5.0%)
were based on the design-based F tests, which is a corrected
weighted Pearson chi square statistic.
Results
Response rate
The response rate in the public opinion survey was 53%
(837 respondents out of an estimated eligible 1551 indivi-
duals). To reach that number of eligible interviews, 5250
calls were made in total, out of which 3699 were not eli-
gible (not Qatari individuals 18+ years).
Respondents’ demographics
The demographic characteristics of respondents are shown
in Table 1. Approximately one-half of the respondents
(49.2%) were male, and the average age of respondents was
~36 years (range 18–75). Over one-half (58.1%) of
respondents were married, 45.1% of those marriages were
consanguineous, and 89% of married respondents reported
having children. Almost 80% of the sample reported a
secondary educational level or higher, and approximately
one-third of respondents (34.0%) reported a monthly
household income of 70 000 QAR (19230 USD) or higher.
Respondents’ knowledge, attitudes, and willingness
Information about genetic or genomic tests, basic literacy in
genetics, past exposure, and family history of disease,
including genetic disease, are presented in Table 2. These
factors are hypothesized to influence interest in genetic or
genomic testing, which may in turn affect willingness to
undergo genomic tests. Almost one-half of respondents
(51.2%) had heard of genetic testing, while only 27.8%
reported having heard of genomic tests. Respondents who
completed higher levels of education, including university
Table 1 Demographic characteristics of public opinion survey
respondents
%a CI% N
Male 49.2 45.6–52.7 478
Age
Mean years (sd) 35.7 (12.7) 34.6–36.7 804
Married 58.1 54.6–61.6 531
Blood related to spouse 45.1 40.8–49.5 241
Has children 89 86.2–91.2 523
Education (highest level)
Less than secondary 20.4 17.6–23.5 159
Secondary or vocational 47.5 44.0–51.0 386
Undergraduate degree or above 32.1 29.0–35.4 289
Monthly household incomeb
Less than ~$8,240 23.1 20.0–26.5 159
~$8,240–$13,730 22.9 19.9–26.1 180
~$13,730–$19,230 20.1 17.3–23.2 152
More than ~$19,230 34 30.5–37.6 251
Total sample sizec — — 834
aReported percentages were calculated using survey weights and
therefore differ from the raw percentages. The number of respondents
reported for each variable corresponds to the unweighted sample
bCategories reported have been converted to USD. Income categories
were reported in Qatari Riyals; 92 observations are missing in this
variable
†Three cases missing from this table due to missing values on key
variables
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degrees and above, were more likely to have heard of genetic
tests compared with those with lower level of education (less
than high school; p= 0.0169; data not shown). For genetic
testing, social media (22.3%) and word of mouth (22.6%)
were the most commonly reported individual sources of
information, while only 9.0% of respondents reported that
physicians were their main source of information on genetic
testing. Books, magazines, and brochures were grouped into
one category, accounting for 31.4% of responses. For
genomic testing, 13.0% of respondents reported that physi-
cians were the main source of information, compared with
30.3% for word of mouth and 20.3% for social media. More
than half of the respondents (56.1%) were able to answer at
least 5 out of 8 genetics-related questions correctly and were
classified as having a “high” level of basic literacy in
genetics.
Respondents reported that their most common experi-
ence with genetic testing by a family member was carrier
testing (premarital testing). Two-thirds of the respondents
(62.1%) reported a family history of diabetes, 12.4% a
family history of cancer, and 20.4% reported a family his-
tory of genetic disorders.
In all, when given a description of the QGP and its aims,
70.9% of respondents indicated their willingness to
participate.
Demographic factors, including age, marital status, con-
sanguinity, and education were not significantly associated
with willingness to participate in genomic testing (Supple-
mentary Table 1). Only one category of monthly income
(8240 Qatari Riyals −21,3730 USD) was significantly asso-
ciated with willingness to participate in genomic testing
(82%). Table 3 presents the willingness of respondents to
participate in genomic testing by a number of non-
demographic factors, which were hypothesized to determine
attitudes. Of those factors, basic literacy in genetics, previous
experience with genetic testing, and a family history of
genetic disorders were significantly and positively associated
with higher willingness to participate in genomic testing
through QGP. Among respondents with a high level of basic
literacy in genetics, 76.4% expressed willingness to partici-
pate in QGP activities compared with 63.9% of respondents
with low levels of basic literacy in genetics. Almost two-
thirds (67.3%) of respondents who reported no experience of
genetic testing by a family member were willing to participate
in genomic testing compared with 76.1% of those who did.
Similarly, almost two-thirds (68.6%) of respondents reporting
no family history of genetic disease said they were willing to
participate in genomic testing compared with almost 80% of
respondents with a family history of genetic disease. A history
of chronic disease in the family was positively – though not
significantly—associated with willingness. Among respon-
dents reporting no family history of chronic disease, 64.9%
were willing to participate in genomic testing compared with
72.6% of respondents with a family history of chronic dis-
ease. Having previously heard of genetic or genomic tests was
not significantly associated with willingness to participate,
Table 2 Information on and experience with genetic testing and
willingness to get tested
%a CI% N
Heard about genomic testing 27.8 24.8–31.0 245
Source of information on genomic testingb
Doctor 13.0 10.5–19.4 35
Word of mouth 30.3 23.1–34.4 69
Website or social media 20.3 16.7–27.0 52
Traditonal media (TV/radio) 10.4 6.7–14.3 24
Newspapers/magazines/brochures/other 26.0 20.8–31.8 63
Heard about genetic testing 51.2 48.2–55.3 447
Source of information on genetic testingc
Doctor 9.0 7.5–13.0 44
Word of mouth 22.6 18.7–26.4 99
Website or social media 22.3 19.7–27.6 104
Traditonal media (TV/radio) 14.7 11.1–17.5 62
Newspapers/magazines/brochures/other 31.4 26.3–34.8 135
Basic literacy in geneticsd
Low 43.9 41.2–48.0 373
High 56.1 52.0–58.8 464
Past experience of genetic testing by a family member
Carrier testing 39.3 34.7–44.2 172
Prenatal/newborn testing 3.4 2.0–5.8 14
Diagnostic testing 1.4 0.6–3.0 7
None 51.2 46.4–56.0 239
Family history of chronic disease
Hypertension 47.1 43.5–50.6 382
Obesity 19.6 16.9–22.6 156
Diabetes 62.1 58.6–65.5 520
Cardiovascular disease 19.5 16.8–22.5 160
Stroke 3.9 2.7–5.4 130
Cancer 12.4 10.1–15.0 97
None 22.9 20.1–26.0 191
Family history of genetic disorders 20.4 17.7–23.4 175
Willingness to paritcipate in QGP genomic
testing
70.9 67.5–74.1 584
aReported percentages were calculated using survey weights and
therefore differ from the raw percentages. The number of respondents
reported for each variable corresponds to the unweighted sample
bTwo cases are missing observations for sources of information on
genomic testing; three cases are missing observations for sources of
information on genetic testing
cBasic literacy in genetics was decided based on the number of correct
responses to a set of 8 questions; Literacy of respondents who
answered 5 or more questions correctly was labeled “high” and literacy
of respondents with less than 5 correct answers was labeled “low”
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and the source of hearing about those tests was also not
significantly associated with willingness (data not shown).
Reasons for willingness or not to participate in
genomic testing
Respondents who indicated their willingness to participate
in QGP genomic testing were asked for the most important
reason for their choice. The top three reasons for will-
ingness to participate were: “to know more about my
health” (43.3%), “to prevent future health conditions”
(26.2%), and “to contribute to science” (15.8%) (Fig. 1a).
Respondents who indicated that they would not be willing
to participate in genomic testing through QGP were asked for
the most important reasons for their refusal (Fig. 1b). The
most frequently cited explanations for not willing to partici-
pate, included “not enough time to participate” (40.3%), “not
having enough information or knowledge” (15.2%), and
“concerns that genomic results not kept private” (9.4%). Less
common reasons were “concerns that genetics is tampering
with God’s will” (4.9%), and “fear of knowing future
diseases” (4.3%). The latter respondents often mentioned that
the future was “best left up to God to decide.”
Discussion
To our knowledge, this study is the first population-based
survey of public attitudes toward genetic testing and genomic
testing in the MENA region. Initially, respondents were asked
about their awareness of genetic testing, and we observed that
slightly more than half of the respondents had previously
heard about genetic tests. We found that attitudes toward
genetic testing were generally positive, with the majority
expressing their willingness to participate in the initiatives of
QGP that include, but are not limited to, promoting and
encouraging genomic research. The positive attitudes toward
genetic testing are consistent with survey findings reported
from the Netherlands [11, 12], United States [13, 14], and
Canada [15], where genetic testing is more common. The
positive attitudes and willingness to participate are of parti-
cular interest, given the concerns that a highly endogamous
population would be opposed to genetic testing on cultural
grounds and fear of stigmatization if associated with a genetic
disease [16, 17]. Nevertheless, there is need for in-depth
qualitative research looking at the public’s beliefs and per-
spectives on genomic testing that may yield questions and
concerns not easily identified in a survey.
In our survey, willingness to participate in QGP activities
was high despite a relatively low level of awareness of
genomic testing. Respondents who indicated their willingness
to participate in genomic testing gave as the most important
reason their desire to know more about their health. This
finding indicates that QGP should have a clear strategy and
policy with regard to returning results and educating the
public and what those results mean in the short- and long-term
for their health and wellbeing. In addition to personal moti-
vations, a combined 21.6% of respondents said they would be
willing to participate for altruistic reasons, namely contribut-
ing to scientific research and to improve Qatar or Qatari
society, indicating that nationalistic attitudes play a secondary
role to concerns about personal health benefits in motivating
participation (Fig. 1a). Understanding the drivers and moti-
vations is important for shaping awareness raising campaigns
and educational messages.
In this survey, respondents were asked to report on any
reason that would choose not to participate in QGP genomic
testing. Almost half (55.5%) of responses were barriers of a
practical rather than attitudinal nature, including not having
enough time or having inadequate information about the
program. At the same time, almost 10% of responses were
related to concerns about the confidentiality of results. This
concern has been reported in a number of studies [13, 14] in







Heard about genomic testing
Yes 73.1 178/241 0.719 (1,812) 0.397
No 70 406/575
Heard about genetic testing
Yes 73.4 323/435 2.435 (1,812) 0.119
No 68.2 261/381
Basic literacy in genetics
Low 63.9 239/362 9.837 (1,812) 0.002
High 76.4 345/454
Past experience of genetic testing by a family member
None 67.3 319/470 6.777 (1,812) 0.0094
Some 76.1 265/346
Family history of chronic disease
None 64.9 123/185 3.691 (1,812) 0.0551
Some 72.6 461/631
Family history of genetic disorders
None 68.6 449/645 7.737 (1,812) 0.0055
Some 79.8 135/171
aReported percentages were calculated using survey weights and
therefore differ from the raw percentages
bThe number of respondents reported for each variable corresponds to
the unweighted sample. N refers to the total number of respondents in
the column while n refers to number of observations in the specific cell
cDesign-based F is a corrected weighted Pearson chi square statistic
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populations where genetic testing is more widespread. While
QGP should conduct general informational campaigns about
the procedure and time involved in genomic testing, it also
needs to communicate clearly to the public the systems and
measures in place to protect patient information. Such com-
munications need to be explicit, user-friendly, and appropriate
to different levels of education.
We had originally anticipated that willingness to parti-
cipate in genomic testing might be influenced by familiarity
and past experiences with genetic testing. Among respon-
dents, the most common experience with genetic testing
was carrier testing, which is expected given that the law in
Qatar requires nationals to take part in premarital genetic
testing. This finding is of interest as it suggests that pre-
marital genetic testing may be a good platform to introduce
information about genomic testing to the public. This
approach suggests the need for involving healthcare pro-
fessionals and health educators in educating the public on
the benefits of genomic analysis. Just as the success of
premarital testing depended greatly on religious support for
its success, genomic testing also needs to engage with key
stakeholders, including healthcare providers and religious
scholars [18, 19].
The survey has several strengths, including a repre-
sentative population-based sample of Qatari nationals and
robust survey methods, which emphasized careful inter-
viewer training to standardize questionnaire administration
and to ensure clarity and salience of terminology in the
respondents’ native language (Arabic). That said, it is
important to recognize that social desirability is difficult to
avoid in attitudinal surveys. Respondents sometimes say
“yes” to questions posed by interviewers or agree with
statements when their true feelings are less positive. This
social desirability bias can arise in spite of the best efforts of
survey designers and interviewers to assure the respondents
that their true opinions are valuable. Thus, the true level of
willingness may be inflated by respondent desires to offer
what they believe to be the socially acceptable answer to the
question. Another limitation of this study is the response
rate, which is a challenge in phone surveys generally.
Interviewers were trained to call make repeated attempts to
reach the sample population, and cases that were difficult to
recruit were referred to the most experienced interviewers.
Relatedly, even if these findings do reflect the true nature
of attitudes about the QGP, it is more difficult to get
respondents to engage in a certain behavior (such as giving a
blood sample) than to answer affirmatively to a survey
questions. The strong levels of support found in this survey
should be interpreted as an indication that the majority of
respondents feel positively inclined toward participation.
Subsequently, QGP should capitalize on that good will by
employing engagement programs to raise public knowledge
thereby widening participation. All in all, it is clear that there
is substantial positive attitudes toward the QGP, yet more
efforts need to be directed toward educational initiatives on
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Fig. 1 a Most important reason
for willingness to participate in
QGP genomic testing. *Based
on the question asked only to
respondents who indicated they
would be willing to participate
in QGP genomic testing (n=
584). b Most common reasons
for unwillingness to participate
in QGP genomic testing. *Based
on the question asked only to
respondents who indicated they
would not be willing to
participate in QGP genomic
testing. Respondents were
allowed to give more than one
answer (n= 232)
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In conclusion, the absence of deep-rooted cultural or
ideological objections to genetic testing and genomic testing
are very encouraging for nascent programs exploring genomic
testing in understudied global populations. However, this
enthusiasm needs to be balanced by a sincere effort to raise
public awareness to quell shared fears and ensure that public
discourse and introduction of genomics program is done in a
culturally sensitive and appropriate manner.
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